Key result
This review describes the physiology of beta-adrenergic receptors, the mechanism of action of beta-blockers, and their place in the therapy of cardiovascular disease.
This article provides a narrative review of the physiology, mechanism of action, and clinical indications for beta-blockers across various cardiovascular diseases.
May aid clinician recall of beta-blocker indications in CVD; leaves open integration of recent trial data.
Beta-blockers are widely used to treat a number of cardiovascular diseases, including heart failure, myocardial infarction, atrial fibrillation, angina and hypertension. By inhibiting the binding of catacholamines to beta receptors in the heart and vasculature, beta-blockers can reduce cardiac contractility, heart rate, blood pressure and cardiac output. A sound understanding of how beta-blockers work and the basis of their recommendation for various indications is needed to promote their safe and effective use in patients. This article briefly describes the physiology of beta-adrenergic receptors, the mechanism of action of beta-blockers and their place in the therapy of cardiovascular disease,
No takes yet. Share an insight, caveat, or question.
Amie Bain (2018) conducted a review in Cardiovascular disease. Beta-blockers was evaluated. This review describes the physiology of beta-adrenergic receptors, the mechanism of action of beta-blockers, and their place in the therapy of cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: